CAPS, a B. Braun company, announces a new sterile compounding outsourcing facility in Phoenix, Arizona, which triples CAPS’ capacity and extends its national reach. With a focus on safety and quality, CAPS has grown into a network of twenty-two 503A regional pharmacies by staying current with the standards required to compound sterile preparations. The new facility will serve as the third CAPS 503B Outsourcing Facility registered with the FDA.

CAPS (A B. Braun Company)